Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01585194
Title Phase II Study of Nivolumab in Combination With Ipilimumab for Uveal Melanoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

uveal melanoma

Therapies

Ipilimumab

Nivolumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.